Literature DB >> 7834

Properties of Fcgamma receptors in normal and malignant human tissues.

R Matre, O Tönder, S Thunold, J H Solhaug.   

Abstract

Properties of the IgG receptors were studied by treating tissue sections or suspensions of peripheral mononuclear cells with various chemical reagents and determining changes in their ability to react with IgG-sensitized erythrocytes (EA). A heterogeneity of the Fc receptors was revealed. Iodoacetamide, 2-mercaptoethanol, sodium azide, EDTA, and a pH varying from 6.0 to 8.2 had no effect on Fc receptors in sections of normal lymphoreticular tissue and malignant tissue. Formaldehyde, low pH, and high salt concentrations affected receptor activity to various degrees. Receptors in liver sections and on monocytes were generally more resistant than receptors in spleen sections and on B lymphocytes. Receptors in malignant tissue behaved either like receptors in spleen or like receptors in liver. Although all tissues were sensitive to periodic acid, the Fc receptors in malignant tissue were always more resistant.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 7834     DOI: 10.1111/j.1365-3083.1976.tb00290.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Ultrastructural demonstration of Fc gamma-receptors in sarcoid skin lesions.

Authors:  J R Bjerke; R Nilsen; R Matre
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

2.  Antibodies to human caudate nucleus neurons in Huntington's chorea.

Authors:  G Husby; L Li; L E Davis; E Wedege; E Kokmen; R C Williams
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

3.  Detection of liver IgG Fc receptors using soluble immune complexes of peroxidase-antiperoxidase. I. Detection in liver tissue from patients with liver diseases.

Authors:  T Shinohara
Journal:  Gastroenterol Jpn       Date:  1981

Review 4.  FcR may function as a progression factor of nonlymphoid tumors.

Authors:  I P Witz; M Ran
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.